Back to Search Start Over

Arzoxifene Eli Lilly

Authors :
Cristina, Marchisano-Karpman
Micheal W, DeGregorio
Source :
IDrugs : the investigational drugs journal. 6(9)
Publication Year :
2003

Abstract

Arzoxifene is a benzothiophene second-generation selective estrogen receptor modulator (SERM) under development by Eli LillyCo as a potential treatment for cancer.

Details

ISSN :
13697056
Volume :
6
Issue :
9
Database :
OpenAIRE
Journal :
IDrugs : the investigational drugs journal
Accession number :
edsair.pmid..........3506249f6cb40477f18147180bbd2eac